Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2007, Vol. 110, No. 12, pp. 3815.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, H.
Right arrow Articles by Ildstad, S. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Xu, H.
Right arrow Articles by Ildstad, S. T.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Next Article next article arrow

InsideBlood

IMMUNOBIOLOGY

Comment on Li et al, page 3926

Xenotransplantation: a step closer to reality?

Hong Xu, Jun Yan, and Suzanne T. Ildstad

INSTITUTE FOR CELLULAR THERAPEUTICS; JAMES GRAHAM BROWN CANCER CENTER

In this issue of Blood, Li and colleagues describe a critical role for B cells in xenoreactivity and provide evidence for marginal zone B cell–NK cell interactions in the regulation of T-independent xenoantibody production.

Solid organ transplantation is the preferred treatment for end-organ failure. Many patients die before a precious organ becomes available due to the donor organ shortage, prompting a strong research focus on xenotransplantation. However, xenotransplantation has remained an elusive goal in solving the organ shortage. Most research to date has focused on preexisting natural antibody and the role of T cells and natural killer (NK) cells in xenoreactivity.1,2 The work of Li and colleagues in this issue of Blood identifies a novel collaboration between marginal zone B (MZB) cells (CD19+CD21highCD23low) and NK cells in the rapid induction of T-cell–independent, non–Gal-xenoantibody production and xenorejection (as shown in the figure).


Figure 1
View larger version (154K):
[in this window]
[in a new window]

 
The authors have demonstrated a novel interaction between marginal-zone B cells and NK cells in xenotransplantation. They have shown that (A) NK-cell help is required for T-independent xenoantibody production using C57BL/6 nude mice as recipients, and (B) depletion of NK cells abrogates xenoantibody production.

 
CD154:CD40 is a specific costimulatory pathway in B-cell activation and antibody production in T-cell–dependent allogeneic3 and xenogeneic4 antigens. In their report, Li and colleagues note that the CD154:CD40 pathway seems to be involved in the inducible T-cell–independent xenoantibody response, as it could be partially suppressed by CD154 blockade, providing indirect evidence that this pathway may be involved in the interaction between MZB and NK cells. The interaction between MZB cells and NK cells for xenoantibody production is independent of IFN-{gamma} production or cytolytic activity by NK cells. These studies suggest that NK cells can regulate MZB-cell function and possibly could be used for cell-based immunotherapy to prevent xenograft rejection. However, caution is needed, given the complexity of non-Gal, T-independent antigens in xenotransplantation. For example, the anti–TNP-Ficoll IgM response is not completely abrogated in MZB-cell–deficient, Pyk-2–deficient mice. Nevertheless, this study provides new insight into the collaborative crosstalk of cell-cell interactions in the regulation of T-independent xenoantibody production. This report also affirms the critical role of B cells not only in allotransplantation,5 but also in xenotransplantation. These findings may provide a mechanistically rational approach for using costimulatory blockade and/or targeting these specific effector cells to promote xenograft acceptance. Perhaps most importantly, Li and colleauges can further test their findings in a normal animal model, which would provide further evidence for their clinical applicability in xenotrans-plantation.

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nat Med 1995; 1:869–873.[CrossRef][Medline] [Order article via Infotrieve]

  2. Baertschiger RM and Buhler LH. Xenotransplantation literature update September-October 2006. Xenotransplantation 2007; 14:83.[CrossRef][Medline] [Order article via Infotrieve]

  3. Bishop GA and Hostager BS. The CD40-CD154 interaction in B cell-T liaisons. Cytokine Growth Factor Rev 2003; 14:297–309.[CrossRef][Medline] [Order article via Infotrieve]

  4. Tai H-C, Campanile N, Ezzelarab M, Cooper DKC, Phelps C. Measurement of anti-CD154 monoclonal antibody in primate sera by competitive inhibition ELISA. Xenotransplantation 2006; 13:566–570.[CrossRef][Medline] [Order article via Infotrieve]

  5. Xu H, Yan J, Huang H, et al. Co-stimulatory blockade of CD154:CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood Prepublished on September 7, 2007, as DOI 10.1182/blood-2006-10-053801.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Rapidly induced, T-cell–independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells
Shengqiao Li, Yehong Yan, Yuan Lin, Dominique M. Bullens, Omer Rutgeerts, Jozef Goebels, Constant Segers, Louis Boon, Ahmad Kasran, Rita De Vos, Christiane Dewolf-Peeters, Mark Waer, and An D. Billiau
Blood 2007 110: 3926-3935. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, H.
Right arrow Articles by Ildstad, S. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Xu, H.
Right arrow Articles by Ildstad, S. T.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020